Dupixent® (dupilumab) Recommended for EU Approval to Treat Chronic Spontaneous Urticaria (CSU) in Young Children with Ongoing Symptoms Despite Treatment

If approved, Dupixent would be the first targeted medicine in the EU indicated for children aged 2 to 11 years with CSU inadequately controlled ...

INmune Bio Inc. (INMB) Discusses MissionEB Phase III Trial and CORDStrom as a Disease-Modifying Therapy for RDEB Transcript

Discusses MissionEB Phase III Trial and CORDStrom as a Disease-Modifying Therapy for RDEB February 26, 2026 1:00 PM ...

Regeneron Pharmaceuticals, Inc.: Dupixent (dupilumab) Recommended for EU Approval to Treat Chronic Spontaneous Urticaria (CSU) in Young Children with Ongoing Symptoms Despite ...

If approved, Dupixent would be the first targeted medicine in the EU indicated for children aged 2 to 11 years with CSU inadequately controlled by standard-of-care antihistamine treatment CSU is a chr ...
OMG! Ubuntu

ONLYOFFICE 9.3 makes document editing easier than ever

A new version of ONLYFFICE Desktop Editors, a open source office suite for Windows, macOS and Linux, is out with a fresh set of features and tools.
The Maravi Post

Truecaller Ads Platform Now Directly Available to Advertisers in South Africa and Kenya via 365 Digital

Truecaller Ads Platform Now Directly Available to Advertisers in South Africa and Kenya via 365 Digital - The Maravi Post ...
The Maravi Post

Allan Ngumuya praises Mutharika’s bold move on Chilima Plane Crash Inquiry

CHICAGO-(MaraviPost)-Former member of Parliament and popular gospel artist Allan Ngumuya has commended President Arthur Peter Mutharika as “Mkulukutamoyo” for instituting a fresh Commission of inquiry ...
The Malaysian Reserve

Lilly’s Olumiant (baricitinib) recommended by CHMP for approval of expanded use in the European Union for adolescents with severe alopecia areata

Lilly has also submitted Olumiant in the U.S. for approval to treat severe AA in adolescents, with a decision expected in the second half of 2026 INDIANAPOLIS, Feb. 27, 2026 /PRNewswire/ — Eli Lilly ...